Literature DB >> 22622564

Alzheimer's disease: A breach in the blood-brain barrier.

Peter Carmeliet, Bart De Strooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22622564     DOI： 10.1038/485451a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

Review 1.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

2.  Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.

Authors:  Robert D Bell; Ethan A Winkler; Itender Singh; Abhay P Sagare; Rashid Deane; Zhenhua Wu; David M Holtzman; Christer Betsholtz; Annika Armulik; Jan Sallstrom; Bradford C Berk; Berislav V Zlokovic
Journal:  Nature       Date:  2012-05-16       Impact factor: 49.962

Review 3.  Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process.

Authors:  Bart De Strooper
Journal:  Physiol Rev       Date:  2010-04       Impact factor: 37.312

Review 4.  The neurovascular link in health and disease: molecular mechanisms and therapeutic implications.

Authors:  Annelies Quaegebeur; Christian Lange; Peter Carmeliet
Journal:  Neuron       Date:  2011-08-11       Impact factor: 17.173

Review 5.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.

Authors:  Eric Karran; Marc Mercken; Bart De Strooper
Journal:  Nat Rev Drug Discov       Date:  2011-08-19       Impact factor: 84.694

6.  Human apoE isoforms differentially regulate brain amyloid-β peptide clearance.

Authors:  Joseph M Castellano; Jungsu Kim; Floy R Stewart; Hong Jiang; Ronald B DeMattos; Bruce W Patterson; Anne M Fagan; John C Morris; Kwasi G Mawuenyega; Carlos Cruchaga; Alison M Goate; Kelly R Bales; Steven M Paul; Randall J Bateman; David M Holtzman
Journal:  Sci Transl Med       Date:  2011-06-29       Impact factor: 17.956

Review 7.  Cerebrovascular disorders: molecular insights and therapeutic opportunities.

Authors:  Erik Storkebaum; Annelies Quaegebeur; Miikka Vikkula; Peter Carmeliet
Journal:  Nat Neurosci       Date:  2011-10-26       Impact factor: 24.884

8.  APOE and Alzheimer disease: a major gene with semi-dominant inheritance.

Authors:  E Genin; D Hannequin; D Wallon; K Sleegers; M Hiltunen; O Combarros; M J Bullido; S Engelborghs; P De Deyn; C Berr; F Pasquier; B Dubois; G Tognoni; N Fiévet; N Brouwers; K Bettens; B Arosio; E Coto; M Del Zompo; I Mateo; J Epelbaum; A Frank-Garcia; S Helisalmi; E Porcellini; A Pilotto; P Forti; R Ferri; E Scarpini; G Siciliano; V Solfrizzi; S Sorbi; G Spalletta; F Valdivieso; S Vepsäläinen; V Alvarez; P Bosco; M Mancuso; F Panza; B Nacmias; P Bossù; O Hanon; P Piccardi; G Annoni; D Seripa; D Galimberti; F Licastro; H Soininen; J-F Dartigues; M I Kamboh; C Van Broeckhoven; J C Lambert; P Amouyel; D Campion
Journal:  Mol Psychiatry       Date:  2011-05-10       Impact factor: 15.992

Review 9.  Cyclophilin A: promising new target in cardiovascular therapy.

Authors:  Kimio Satoh; Hiroaki Shimokawa; Bradford C Berk
Journal:  Circ J       Date:  2010-10-15       Impact factor: 2.993

10.  ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.

Authors:  Paige E Cramer; John R Cirrito; Daniel W Wesson; C Y Daniel Lee; J Colleen Karlo; Adriana E Zinn; Brad T Casali; Jessica L Restivo; Whitney D Goebel; Michael J James; Kurt R Brunden; Donald A Wilson; Gary E Landreth
Journal:  Science       Date:  2012-02-09       Impact factor: 47.728
  10 in total
  11 in total

1.  Blood cells and endothelial barrier function.

Authors:  Stephen F Rodrigues; D Neil Granger
Journal:  Tissue Barriers       Date:  2015-04-03

2.  Nanoparticle-based evaluation of blood-brain barrier leakage during the foreign body response.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  J Neural Eng       Date:  2013-01-21       Impact factor: 5.379

3.  Compensating for synaptic loss in Alzheimer's disease.

Authors:  Kamal Abuhassan; Damien Coyle; Ammar Belatreche; Liam Maguire
Journal:  J Comput Neurosci       Date:  2013-06-02       Impact factor: 1.621

4.  Practical detection of a definitive biomarker panel for Alzheimer's disease; comparisons between matched plasma and cerebrospinal fluid.

Authors:  Joanna L Richens; Kelly-Ann Vere; Roger A Light; Daniele Soria; Jonathan Garibaldi; A David Smith; Donald Warden; Gordon Wilcock; Nin Bajaj; Kevin Morgan; Paul O'Shea
Journal:  Int J Mol Epidemiol Genet       Date:  2014-05-29

5.  Investigating the association of ApoE genotypes with blood-brain barrier dysfunction measured by cerebrospinal fluid-serum albumin ratio in a cohort of patients with different types of dementia.

Authors:  André Karch; Henrike Manthey; Claudia Ponto; Peter Hermann; Uta Heinemann; Christian Schmidt; Inga Zerr
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

6.  HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.

Authors:  Barry W Festoff; Ravi K Sajja; Patrick van Dreden; Luca Cucullo
Journal:  J Neuroinflammation       Date:  2016-08-24       Impact factor: 8.322

7.  Increasing of Blood Brain Barrier Permeability and the Association With Depression and Anxiety in Systemic Lupus Erythematosus Patients.

Authors:  Xiangyu Wang; Lihua Ma; Yuli Luo; Yifan Yang; Bibhuti Upreti; Yuqi Cheng; Ruomei Cui; Shuang Liu; Jian Xu
Journal:  Front Med (Lausanne)       Date:  2022-03-29

8.  Gene networks specific for innate immunity define post-traumatic stress disorder.

Authors:  M S Breen; A X Maihofer; S J Glatt; D S Tylee; S D Chandler; M T Tsuang; V B Risbrough; D G Baker; D T O'Connor; C M Nievergelt; C H Woelk
Journal:  Mol Psychiatry       Date:  2015-03-10       Impact factor: 15.992

Review 9.  Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence.

Authors:  Souhel Najjar; Daniel M Pearlman; Orrin Devinsky; Amanda Najjar; David Zagzag
Journal:  J Neuroinflammation       Date:  2013-12-01       Impact factor: 8.322

10.  BBBomics-Human Blood Brain Barrier Transcriptomics Hub.

Authors:  Krishna R Kalari; Kevin J Thompson; Asha A Nair; Xiaojia Tang; Matthew A Bockol; Navya Jhawar; Suresh K Swaminathan; Val J Lowe; Karunya K Kandimalla
Journal:  Front Neurosci       Date:  2016-03-01       Impact factor: 4.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.